Masters of Pathology Series

Stay Current in a Rapidly Changing Field

This CME program, featuring experts in the practice of Breast Pathology, is a comprehensive review of the core concepts and emerging trends in the field. Masters of Pathology Series – Breast Pathology covers updates on ER/PR/HER2 testing, contemporary issues in core needle biopsy, deceptive patterns and mimics of invasive breast cancer, and more. It will help you to better:

• Evaluate diagnostic criteria and clinical significance of common and uncommon benign, in situ, and malignant lesions
• Address differential diagnostic problems commonly encountered in breast pathology
• Gain the latest information on the uses and limitations of IHC in diagnostic breast pathology
• Understand the latest guidelines for ER, PR and HER2 testing and reporting

Expand Your Skills

Available online, Masters of Pathology Series – Breast Pathology provides a maximum of 13.5 AMA PRA Category 1 Credits ™ and access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice.

• Atypical Ductal Proliferations – Melinda J. Lerwill, MD

• Lobular Carcinoma in Situ; Classical and Non-classical Forms – Laura C. Collins, MD

• Ductal Carcinoma in Situ: Diagnostic Evaluation and Problematic Patterns – Melinda J. Lerwill, MD

• Papillary Lesions – Laura C. Collins, MD

• Fibroepithelial Neoplasms – Melinda J. Lerwill, MD

• Mucinous Lesions – Laura C. Collins, MD

• Specimen Handling, Margin Evaluation and Reporting – Melinda J. Lerwill, MD

• Current Issues for Core Needle Biopsy of the Breast – Laura C. Collins, MD

• Evaluation of Cancers Treated with Neoadjuvant Systemic Therapy – Melinda J. Lerwill, MD

• ER/PR/HER2 Testing-Updates – Laura C. Collins, MD

• Spindle Cell Lesions – Melinda J. Lerwill, MD

• Special Types of Invasive Breast Cancers – Laura C. Collins, MD

• Deceptive Patterns and Mimics of Invasive Breast Cancer – Melinda J. Lerwill, MD

• Newer Prognostic and Predictive Factors – Laura C. Collins, MD

• Nipple Lesions – Laura C. Collins, MD

• Vascular Lesions – Melinda J. Lerwill, MD